Author

Donovan Worrall

Montreal Neurological Institute and HospitalORCID 0000-0001-5676-5473Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Assay:fluorescence / live-cell microscopy· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Assay:GWAS summary statistics· 1

Frequent Co-Authors

A.M. EdwardsiD· 1 shared Anita E. BandrowskiiD· 1 shared Carl LaflammeiD· 1 shared Claire M. BrowniD· 1 shared Cloe Chantereault· 1 shared Edward A. FoniD· 1 shared Eric YuiD· 1 shared Harvinder S VirkiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

A.M. EdwardsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintFeb 11, 2026

Machine learning and burden analyses highlight novel candidate genes in Parkinson's disease

Sitki Cem Parlar, Eric Yu, Sajanth Kanagasingam…·Ziv Gan‐Or

The paper integrates machine learning and rare variant burden analysis to identify novel candidate genes for Parkinson's disease.

DOI 10.64898/2026.01.22.26344646

humanGWAS summary statistics

𝕏 PostBluesky

Molecular BiologyeLifePeer-reviewedOct 5, 2023

✦ In-depth digest

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications

Riham Ayoubi, Joël Ryan, Michael Biddle…·Carl Laflamme

Over half of 614 commercial antibodies for 65 human neuroscience proteins failed a knockout-controlled assay, yet most targets had a well-performing antibody; recombinants performed best.

68 citationstop 1%

humanfluorescence / live-cell microscopy

𝕏 PostBluesky